Malabaricon C (standaard)

Malabaricone C is an orally active and noncompetitive sphingomyelin synthase (SMS) inhibitor with IC50 values of 3 μM and 1.5 μM for SMS 1 and SMS 2, respectively. Malabaricone C reduces body weight gain, improves glucose tolerance, and decreases lipid accumulation in the liver, showing significant prevention of high fat diet-induced fatty liver in mice. Malabaricone C has anti-inflammatory effects, which is found in the fruits of Myristica cinnamomea King. Malabaricone C is promising for research of obesity and immunological disorders caused due to hyper-activation of T-cells[1][2][3].

63335-25-1

12352005

Apoptosis; NF-κB; p38 MAPK; Phospholipase

Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB

Cancer; Metabolic Disease; Inflammation/Immunology

O=C(C1=C(O)C=CC=C1O)CCCCCCCCC2=CC=C(O)C(O)=C2

C21H26O5

358.43

[1]Othman MA, et al. Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice. ACS Med Chem Lett. 2019;10 (8) :1154-1158. Published 2019 Jul 3.|[2]Patwardhan RS, et al. Malabaricone C, a constituent of spice Myristica malabarica, exhibits anti-inflammatory effects via modulation of cellular redox. J Biosci. 2023;48 (2) :9.|[3]Tyagi M, et al. Mechanism of the malabaricone C-induced toxicity to the MCF-7 cell line. Free Radic Res. 2014 Apr;48 (4) :466-77.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-N8518R/

Reference Standards